000 01082 a2200313 4500
005 20250517142139.0
264 0 _c20190709
008 201907s 0 0 eng d
022 _a1944-446X
024 7 _a10.1186/s40880-017-0194-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPeng, Shihong
245 0 0 _aAilanthone: a new potential drug for castration-resistant prostate cancer.
_h[electronic resource]
260 _bChinese journal of cancer
_c03 2017
300 _a25 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Comment
650 0 4 _aBenzamides
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNitriles
650 0 4 _aPhenylthiohydantoin
_xanalogs & derivatives
650 0 4 _aProstatic Neoplasms
650 0 4 _aProstatic Neoplasms, Castration-Resistant
650 0 4 _aQuassins
700 1 _aYi, Zhengfang
700 1 _aLiu, Mingyao
773 0 _tChinese journal of cancer
_gvol. 36
_gno. 1
_gp. 25
856 4 0 _uhttps://doi.org/10.1186/s40880-017-0194-7
_zAvailable from publisher's website
999 _c26933475
_d26933475